Nancy Jean Woolf

age ~71

from Las Vegas, NV

Get Report

Also known as:

Connected to:

Nancy Woolf Phones & Addresses

view source

Specialties:

Neurology
Psychiatry
Adolescent Medicine

view source

ISLN:

902624304

Admitted:

1984

University:

University of Massachusetts, B.S., 1980

Law School:

University of Wisconsin-Madison, J.D., 1984

Name / Title

Company / Classification

Phones & Addresses

Nancy Woolf
Adjt Professional Psych-behav Neurosci

University of California, Los Angeles
Noncommercial Research Organizations

10945 Le Conte Ave, Los Angeles, CA 90095

Process For Treating Disease
view source
US Patent:

20030073608, Apr 17, 2003
Filed:

Apr 10, 2001
Appl. No.:

09/832015
Inventors:

Nancy Woolf - Studio City CA, US
Howard Greenwald - Penfield NY, US
International Classification:

A61K031/00
A61K009/22
US Classification:

514/001000, 424/468000, 424/423000
Abstract:

A process for treating Alheimer's disease, comprising the steps of administering to a human patient an antagonist of a neurotransmitter receptor which indirectly inhibits phosporylation of microtubule-associated protein-2, and thereafter administering to said patient and anticholinesterase agent. The antagonist of the neurotransmitter binds to a neurotransmitter receptor which phosphorylates said microtubule-associated protein-2 in limbic cells, the antagonist of the neurotransmitter binds to a neurotransmitter receptor which phosphorylates microtuble-associated protein-2 in neocortical cells, and the antagonist binds to said neurotransmitter receptor in said limbic cells at least 1.5 times as much as it binds to said neurotransmitter receptor in said neocortical cells.

Drug Delivery Apparatus Utilizing Cantilever
view source
US Patent:

20050265991, Dec 1, 2005
Filed:

May 28, 2004
Appl. No.:

10/857279
Inventors:

Jack Tuszynski - Edmonton, CA
Nancy Woolf - Studio City CA, US
International Classification:

A61K039/395
A61K031/337
A61K009/22
US Classification:

424130100, 514449000, 604890100
Abstract:

Disclosed is a device which employs a chemically sensitive cantilever hingably attached to a capsule. The cantilever functions as a switch which regulates the flow of particles into and/or out of the capsule.

Method For Treating Alzheimer's Disease Using Superior Stability Tubulin Consructs
view source
US Patent:

20160361385, Dec 15, 2016
Filed:

Jun 13, 2016
Appl. No.:

15/180764
Inventors:

Jack A. Tuszynski - Edmonton, CA
Nancy Woolf - Las Vegas NV, US
International Classification:

A61K 38/17
Abstract:

A method of providing a therapeutic benefit to a patient for Alzheimer's Disease (AD) is disclosed. A superior stabilizing-tubulin (SS-tubulin) is administered, either directly or indirectly through gene therapy. Mutated alpha SS-tubulins and mutated beta SS-tubulins are disclosed for use in the method.